Evaluate the Pharmacokinetics of BMS-986177 From Two Formulations in Healthy Participants

NCT03362437 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis

Interventions

DRUG: BMS-986177
DRUG: BMS-986177

Sponsor

Bristol-Myers Squibb